The 6 most recent market catalysts affecting $PLXS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 22, 2026
Corporate Catalyst
Bullish
Impact 65
This Plexus Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
The filing highlights five distinct analyst upgrades across different sectors, with Plexus Corp. being the primary focus of the headline. Analyst upgrades typically signal improved…
Sep 22, 2026
Corporate Catalyst
Bullish
Impact 65
Keybanc Upgrades Plexus to Overweight, Announces $300 Price Target
Keybanc analyst Steve Barger upgraded Plexus (PLXS) from 'Sector Weight' to 'Overweight' and established a $300 price target. This action indicates a more bullish outlook on Plexus…
Aug 24, 2026
Corporate Catalyst
Neutral
Impact 65
Plexus Approved New $100M Buyback Program On August 20
Plexus Corp. (PLXS) has approved a new share repurchase program, allowing the company to buy back up to $100 million of its common stock. This move is generally viewed positively b…
Jul 29, 2026
Corporate Catalyst
Neutral
Impact 75
Plexus Sees Q4 GAAP EPS $2.18-$2.34 vs $2.11 Est
Plexus (PLXS) has issued Q4 GAAP EPS guidance ranging from $2.18 to $2.34, which significantly surpasses the consensus analyst estimate of $2.11. This indicates that the company an…
Jul 29, 2026
Corporate Catalyst
Neutral
Impact 85
Plexus Sees Q4 Adj EPS $2.47-$2.63 vs $2.25 Est; Sees Sales $1.330B-$1.380B vs $1.260B Est
Plexus (PLXS) has released Q4 guidance indicating adjusted EPS of $2.47-$2.63 and sales of $1.330 billion-$1.380 billion. These figures are substantially higher than the analyst co…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 95
Plexus Q3 Adj. EPS $2.32 Beats $2.12 Estimate, Sales $1.305B Beat $1.229B Estimate
Plexus announced its Q3 earnings, reporting adjusted EPS of $2.32 and sales of $1.305 billion, both substantially exceeding analyst consensus estimates. This strong performance, wi…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.